AB0583 DIFFERENCES BETWEEN ISOLATED AORTITIS AND NON-INFECTIOUS AORTITIS SECONDARY TO OTHER ENTITIES. STUDY OF 93 PATIENTS FROM A SINGLE CENTER
Background: Non-infectious aortitis is an inflammation of aortic wall which may be isolated or associated with a cluster of diseases. Objectives: Our aim was to compare the clinical and laboratory findings of patients with isolated aortitis and patients with aortitis secondary to other underlying conditions. Methods: Retrospective study of 93 patients with non-infectious aortitis diagnosed by PET/CT scan from a referral center from January 2010 to December 2016. We have considered two groups: group a) isolated aortitis; and group b) secondary aortitis. Distributions of categorical variables were compared by the Pearson Chi 2 or Fisher exact test. Quantitative variables were analyzing using the Student t test or Mann-Whitney U test as appropriate. Results: Ninety-three patients were diagnosed with non-infectious aortitis. One patient was excluded due to missing data. Group a) was composed by 54 patients (34 women/ 20 men) with a mean age of 67±11 years; group b) comprised 38 patients (28 women/ 10 men) with a mean age of 68±11 years. In this group, the underlying conditions we found were: giant cell arteritis (n=24), Takayasu arteritis (n=3), spondiloarthropathy (n=3), Sjögren's syndrome (n=3), ulcerative colitis (n=2), sarcoidosis (n=1), rheumatoid arthritis (n=1), polyarteritis nodosa (n=1). The comparative study between both groups is shown in the Background: Aortitis is the inflammation of the aortic wall. This entity is often under-recognised due to its frequent presentation with non-specific symptoms. PET/CT scan represent a major breakthrough to establish an early diagnosis, but this is an expensive technique. Objectives: Our aim was to compare the baseline characteristics of patients with a suspicion of aortitis and positive results on PET/CT scan, and those with a negative result, in order to search for predictive factors, that improve the clinical probability of diagnosis aortitis by this imaging technique. Methods: Retrospective study on 170 patients and PET/CT scans ordered by suspicion of aortitis from a referral center from January 2010 to December 2016. According to a pre-specified protocol, the baseline epidemiological and clinical variables of patients with positive and negative PET/CT scans results for aortitis were reviewed. Distributions of categorical variables were compared by the Pearson Chi 2 or Fisher exact test. Quantitative variables were analyzing using the Student t test or Mann-Whitney U test as appropriate. Results: In 170 patients, PET/CT scans were performed due to clinical suspicion of aortitis, and were positive in 93 (54.7%) cases. Patients (113 women/57 men) had a mean age of 67.7±13.1 years (range, 20-90 years). One patient was excluded because missing clinical or laboratory data. The underlying diseases at the moment of ordering the PET/CT scan were: giant cell arteritis (GCA) (n=28), spondiloarthropaties (n=7), conectivopaties (n=6), Takayasu arteritis (n=3), ulcerative colitis (n=3), other condition (n=11). The remaining 111 patients did not have any underlying condition suggestive of aortitis. Two out of 170 patients suspected an infectious aortitis (Brucella and Salmonella); however, PET/CT was negative in both cases. Characteristics of patients with positive and negative PET/CT scans were summarized in the Table. Patients with GCA had a higher percentage of positive PET/CT scans, whereas they were negative more frequently in patients who did not have any condition suggestive of underlying aortitis. Only inflammatory low back pain and polymyalgic syndrome were significantly more frequent in patients with positive PET/CT scans. The remaining clinical and laboratory variables did not show differences between both groups.
Conclusions:
In this study, we have found that the presence of inflammatory low back pain and polymyalgic syndrome, especially in GCA patients, may have clinical relevance in ordering a PET/CT scan when aortitis was suspected. Results: They were 61 GPA (34 men and 27 women) mean age 42 years old at diagnosis. Systemic form was observed in 53% and localized form 47%. Chronic sinusitis was the most frequent manifestation in 33% followed by otologic in 26%. Subglottic stenosis 4 patients, alveolar hemorrhage 1%. Of the patients with the systemic form 22 presented focal and segmental glomerulonephritis and 10 patients (32%) rapidly progressive glomerulonephritis. Distal-symmetric polyneuropathy and cranial neuropathy were present in 24%; scleritis 24.5% and proptosis in 18%, palpable purpura 26.2% and ulcers in 9 patients (14.8%). The VDI score in the systemic form was 3.8 and in the localized 2.6, p= NS. The disease related damage was pronounced in kidneys and upper airways. The majority of patients in the induction to remission phase received steroids plus cyclophosphamide, 7 patients also received plasmapheresis and in maintenance phase they were treated with methotrexate or azathioprine. Conclusions: In this cohort of patients with GPA, a high chronic damage was found which was similar in both systemic and localized forms of this vasculitis. The VDI was more prominent in kidneys and upper airways in GPA patients Background: Takayasu Arteritis is a rare large-vessel vasculitis variant that affects the aorta and its main branches and the pulmonary arteries. Antiphospholipid syndrome is characterized by obstetric and thrombotic complications in the presence of antiphospholipid antibodies, which consist of anticardiolipin antibody, lupus anticoagulant and anti -β2 glycoprotein I. The association of antiphospholipid antibodies and Takayasu arteritis is very rare and few cases decumented it, while others argued aganist such association. Objectives: This study was planned to find out the prevelance of immunoglobulinIgM/G anti-cardiolipinantibodies, anti beta 2 glycoprotein-1antibodies and lupus anticogulant and evaluate the relationship between these antibodies and disease severity/complications in Takayasu arteritis patients. Methods: 53 patients with Takayasu arteritis patients were enrolled in this study. We obtained blood samples to detectIgM/G anti-cardiolipin antibodies, anti beta 2 glycoprotein 1 antibodies and lupus anticogulant (LA) levels from all patients during their routine control. ImmunoglobulinIgM/G anti-cardiolipin antibody, anti beta 2 glycoprotein 1 antibodies were measured by using a standardized enzymelinked immunosorbent assay (ELISA) and lupus anticogulant was measured using the diluteRussell's viper venom time (dRVVT). Results: No patients was positive forIgM/G anti-cardiolipin antibody. Seven were positive immunoglobulin IgM anti beta 2 glycoprotein 1 antibodies, three were positive immunoglobulin IgG anti beta 2 glycoprotein 1 antibodies, one waspositive LA. All of the antibody titters were low. TA patients who had antibody positivity had longer disease duration (p<0.05). Antibody and LA positive patients had superior mesenteric artery and celiac artery involvement more frequently then the antibody negative patients (p<0.05). Conclusions: In this study that there were no association between the antibodies positivity and vascular involvement or disease complications and severity in TA patients. In conclusion we can not suggest the routine evaluation of antiphospholipid antibodies or lupus anticoagulant test during the follow-upTakayasu arteritis patients. These antibodies may only be measured in the presence of clinical suspicion. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.3529 
